Vikram Thermo (India) Ltd
NSE: BSE: 530477
₹136.10
(-2.99%)
Tue, 07 Apr 2026, 07:09 pm
Market Cap4.27B
PE Ratio12.53
Dividend0.71
Health Technology
Pharmaceuticals: Major
24.5KVikram Thermo (India) Analysis
dividend
- Dividends per share have increased over the past 10 years.
- Dividends paid are thoroughly covered by earnings (9.2x coverage).
- Vikram Thermo (India)'s pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Vikram Thermo (India)'s dividend is below the markets top 25% of dividend payers in India (3.08%).
health
- Vikram Thermo (India) is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Vikram Thermo (India) is profitable, therefore cash runway is not a concern.
- Vikram Thermo (India) is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (51.8%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 4.9x debt.
- Vikram Thermo (India)'s cash and other short term assets cover its long term commitments.
- Interest payments on debt are well covered by earnings (EBIT is 15.6x coverage).
- Vikram Thermo (India)'s level of debt (14%) compared to net worth is satisfactory (less than 40%).
- The level of debt compared to net worth has increased over the past 5 years (12.4% vs 14% today).
- High level of physical assets or inventory.
management
- The average tenure for the Vikram Thermo (India) board of directors is over 10 years, this suggests they are a seasoned and experienced board.
- Dhirajlal's remuneration is about average for companies of similar size in India.
- Dhirajlal's compensation has been consistent with company performance over the past year, both up more than 20%.
misc
- Vikram Thermo (India) is not covered by any analysts.
- Vikram Thermo (India) has significant price volatility in the past 3 months.
past
- Vikram Thermo (India)'s 1-year earnings growth exceeds its 5-year average (110.7% vs 15.2%)
- Vikram Thermo (India)'s year on year earnings growth rate has been positive over the past 5 years.
- Vikram Thermo (India) used its assets more efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
- Vikram Thermo (India) has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
- Vikram Thermo (India)'s earnings growth has exceeded the IN Pharmaceuticals industry average in the past year (110.7% vs 22.7%).
- Vikram Thermo (India) has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
value
- Vikram Thermo (India) is good value based on assets compared to the IN Pharmaceuticals industry average.
- Vikram Thermo (India) is good value based on earnings compared to the IN Pharmaceuticals industry average.
- Vikram Thermo (India) is good value based on earnings compared to the India market.
- 530477 outperformed the Market in India which returned -14.5% over the past year.
- BSE:530477 is up 18.5% outperforming the Pharmaceuticals industry which returned 6.8% over the past month.
- BSE:530477 is up 18.5% outperforming the market in India which returned 8% over the past month.
- Vikram Thermo (India)'s share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Vikram Thermo (India)'s share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- 530477 underperformed the Pharmaceuticals industry which returned 26.7% over the past year.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800